Skip to main content
SpringerLink
Log in

Reciptrocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Genes encoding numerous proto-oncogenes and cytokines, as well as a number of G-protein coupled receptors, are regulated post-transcriptionally at the level of mRNA stability. A common feature of all of these genes is the presence of A + U-rich elements (AREs) within their 3′ untranslated regions. We, and others, have demonstrated previously that mRNAs encoding beta-adrenergic receptors (β-ARs) are destabilized by agonist stimulation of the β-AR/Gαs/adenylylcyclase pathway. However, in addition to PK-A, β-ARs can also activate or inhibit mitogen activated kinase (MAPK) cascades, in a cell-type dependent basis.

Recent evidence points to an important role for MAPKs in regulating the turnover of cytokine mRNAs, such as TNFα. We hypothesized that activation of MAPK's may also regulate β-AR mRNA stability. The studies conducted herein demonstrate that generalized stimulation of MAPKs (JNK, p38) with anisomycin resulted in marked stabilization of β-AR mRNA. Reciprocally, selective inhibition of JNK with SP600125 significantly decreased β-AR mRNA half-life. Similarly, inhibition of the MEK/ERK pathway with either PD98059 or U0126 decreased β-AR mRNA stability substantially. However, inhibition of p38 MAPK with SB203580 produced destabilization of β-AR mRNA only at higher, non pharmacologically selective concentrations. In contrast to their effects on several other ARE containing mRNAs, inhibition of tyrosine kinases by genistein or PI3K by wortmannin, had no detectable effect on β-AR mRNA stability. In summary, these results demonstrate for the first time that modulation of MAPK pathways can bi-directionally influence β-AR mRNA stability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Communal C, Singh K, Sawyer DB, Colucci WS: Opposing effects of beta(1)-and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein. Circulation 100: 2210–2212, 1999

    Google Scholar 

  2. Danner S, Frank M, Lohse MJ: Agonist regulation of human β2-adrenergic receptor mRNA stability occurs via a specific AU-rich element. J Biol Chem 273: 3223–3229, 1998

    Google Scholar 

  3. Hadcock JR, Wang H-y, Malbon CC: Agonist-induced destabilization of β-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of β-adrenergic receptors. J Biol Chem 264: 19928–19933, 1989

    Google Scholar 

  4. Tholanikunnel BG, Malbon CC: A 20-nucleotide (A + U)-rich element of the β2-adrenergic receptor (β2-AR) mRNA mediates binding to the β2-AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA. J Biol Chem 272: 11471–11478, 1997

    Google Scholar 

  5. Mitchusson KD, Blaxall BC, Pende A, Port JD: Agonist-mediated destabilization of human beta1-adrenergic receptor mRNA: Role of the 3′ untranslated translated region. Biochem Biophys Res Commun 252: 357–362, 1998

    Google Scholar 

  6. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, Kollias G: Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. Embo J 20: 3760–3770, 2001

    Google Scholar 

  7. Ming XF, Kaiser M, Moroni C: c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. Embo J 17: 6039–6048, 1998

    Google Scholar 

  8. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH: Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 314: 115–121, 1996

    Google Scholar 

  9. Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka B, Xiao RP: Beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by PKA rather than by Gi or Gbeta gamma in adult mouse cardiomyocytes. J Biol Chem 275: 40635–40640, 2000

    Google Scholar 

  10. Kirigiti P, Bai Y, Yang YF, Li X, Li B, Brewer G, Machida CA: Agonist-mediated down-regulation of rat beta1-adrenergic receptor transcripts: Role of potential post-transcriptional degradation factors. Mol Pharmacol 60: 1308–1324, 2001

    Google Scholar 

  11. Blaxall BC, Pellett AC, Wu SC, Pende A, Port JD: Purification and characterization of beta-adrenergic receptor mRNA-binding proteins. J Biol Chem 275: 4290–4297, 2000

    Google Scholar 

  12. Blaxall BC, Pende A, Wu SC, Port JD: Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNP D) and HuR for A + U-rich mRNAs. Mol Cell Biochem 232: 1–11, 2002

    Google Scholar 

  13. Pende A, Tremmel KD, DeMaria CT, Blaxall BC, Minobe W, Sherman JA, Bisognano J, Bristow MR, Brewer G, Port JD: Regulation of the mRNA-binding protein AUF1 by activation of the β-adrenergic receptor signal transduction pathway. J Biol Chem 271: 8493–8501, 1996

    Google Scholar 

  14. Port JD, Huang L-Y, Malbon CC: β-adrenergic agonists that down-regulate receptor mRNA up-regulate a Mr 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNAs. J Biol Chem 267: 24103–24108, 1992

    Google Scholar 

  15. Tholanikunnel BG, Granneman JG, Malbon CC: The Mr 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J Biol Chem 270: 12787–12793, 1995

    Google Scholar 

  16. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD: Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinogen 28: 76–83, 2000

    Google Scholar 

  17. Danner S, Lohse MJ: Cell type-specific regulation of β2-adrenoceptor mRNA by agonists. Eur J Pharmacol 331: 73–78, 1997

    Google Scholar 

  18. Izzo N, Seidman CE, Collins S, Colucci WS: α1-Adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells. Proc Natl Acad Sci USA 87: 6268–6271, 1990

    Google Scholar 

  19. Izzo N, Tulenko T, Colucci W: Phorbol esters and norepinephrine destabilize α1b-adrenergic receptor mRNA in vascular smooth muscle cells. J Biol Chem 269: 1705–1710, 1994

    Google Scholar 

  20. Tholanikunnel BG, Raymond JR, Malbon CC: Analysis of the AU-rich elements in the 3′-untranslated region of beta 2-adrenergic receptor mRNA by mutagenesis and identification of the homologous AU-rich region from different species. Biochemistry 38: 15564–15572, 1999

    Google Scholar 

  21. Li Z, Vaidya VA, Alvaro JD, Iredale PA, Hsu R, Hoffman G, Fitzgerald L, Curran PK, Machida CA, Fishman PH, Duman RS: Protein kinase C-mediated down-regulation of beta 1-adrenergic receptor gene expression in rat C6 glioma cells. Mol Pharmacol 54: 14–21, 1998

    Google Scholar 

  22. Zweifach A: Target-cell contact activates a highly selective capacitative calcium entry pathway in cytotoxic T lymphocytes. J Cell Biol 148: 603–614, 2000

    Google Scholar 

  23. Grynkiewicz G, Poenie M, Tsien R: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440–3450, 1985

    Google Scholar 

  24. Hadcock JR, Malbon CC: Down-regulation of β-adrenergic receptors: Agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA 85: 5021–5025, 1988

    Google Scholar 

  25. Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J: Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 275: 26484–26491, 2000

    Google Scholar 

  26. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR: Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21: 6461–6469, 2001

    Google Scholar 

  27. Sirenko OI, Lofquist AK, DeMaria CT, Morris JS, Brewer G, Haskill JS: Adhesion-dependent regulation of an A + U-rich element-binding activity associated with AUF1. Mol Cell Biol 17: 3898–3906, 1997

    Google Scholar 

  28. Sabri A, Pak E, Alcott SA, Wilson BA, Steinberg SF: Coupling function of endogenous alpha(1)-and beta-adrenergic receptors in mouse cardiomyocytes. Circ Res 86: 1047–1053, 2000

    Google Scholar 

  29. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz RJ: Role of c-Src tyrosine kinase in G protein-coupled receptor-and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271: 19443–19450, 1996

    Google Scholar 

  30. Communal C, Colucci WS, Remondino A, Sawyer DB, Port JD, Wichman SE, Bristow MR, Singh K: Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium. J Card Fail 8: 86–92, 2002

    Google Scholar 

  31. Lemke LE, Bloem LJ, Fouts R, Esterman M, Sandusky G, Vlahos CJ: Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. J Mol Cell Cardiol 33: 1527–1540, 2001

    Google Scholar 

  32. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD: The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. Embo J 19: 6341–6350, 2000

    Google Scholar 

  33. Bohm M, Reiger B, Schwinger RH, Erdmann E: cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res 28: 1713–1719, 1994

    Google Scholar 

  34. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR, Saklatvala J: A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett 439: 75–80, 1998

    Google Scholar 

  35. Westmark CJ, Malter JS: Up-regulation of nucleolin mRNA and protein in peripheral blood mononuclear cells by extracellular-regulated kinase. J Biol Chem 276: 1119–1126, 2001

    Google Scholar 

  36. Ming XF, Stoecklin G, Lu M, Looser R, Moroni C: Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell Biol 21: 5778–5789, 2001

    Google Scholar 

  37. Reunanen N, Li S-P, Ahonen M, Foschi M, Han J, Kahari V-M: Activation of p38alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 277: 32360–32368, 2002

    Google Scholar 

  38. Lee NH, Malek RL: Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity. J Biol Chem 273: 22317–22325, 1998

    Google Scholar 

  39. Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, Jetten AM: Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 274: 29138–29148, 1999

    Google Scholar 

  40. Sheng H, Shao J, Dubois RN: K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res 61: 2670–2675, 2001

    Google Scholar 

  41. Chesley A, Lundberg MS, Asai T, Xiao R-P, Ohtani S, Lakatta EG, Crow MT: The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 87: 1172–1179, 2000

    Google Scholar 

  42. Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001–1005, 1998

    Google Scholar 

  43. Zhu W, Brauchle MA, Di Padova F, Gram H, New L, Ono K, Downey JS, Han J: Gene suppression by tristetraprolin and release by the p38 pathway. Am J Physiol Lung Cell Mol Physiol 281: L499–L508, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, 80262, USA

    Violetta V. Headley, Rasheeda Tanveer, Scott M. Greene & J. David Port

  2. Department of Pharmacology and Department of Physiology, University of Colorado Health Sciences Center, Denver, CO, 80262, USA

    Adam Zweifach

Authors
  1. Violetta V. Headley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rasheeda Tanveer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott M. Greene
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adam Zweifach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. David Port
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Headley, V.V., Tanveer, R., Greene, S.M. et al. Reciptrocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition. Mol Cell Biochem 258, 109–119 (2004). https://doi.org/10.1023/B:MCBI.0000012841.03400.42

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000012841.03400.42

Search

Navigation